OX40-TRAF6轴促进CTLA-4降解以增强抗瘤CD8+T细胞免疫力
Jizhang Yu1,2,3,4, Jikai Cui1,2,3, Xi Zhang1,2,3
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cellular & molecular immunology
|November 6, 2023
概括
通过向OX40-TRAF6通路来增强瘤免疫力,该通路降解细胞毒性T淋巴细胞相关蛋白4 (CTLA-4). 这一发现为改善癌症免疫疗法提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子机制的分子机制
背景情况:
- 免疫检查点阻塞 (ICB) 疗法,如抗细胞毒性T-淋巴细胞相关蛋白4 (CTLA-4),在许多癌症患者中显示出有限的疗效.
- 了解CTLA-4调节对于克服对ICB的耐药性和开发改进的免疫疗法至关重要.
研究的目的:
- 阐明控制CTLA-4蛋白稳定性的调控机制及其对抗瘤免疫力的影响.
- 确定新的治疗点,以提高基于T细胞的癌症免疫疗法的有效性.
主要方法:
- 通过生物化学分析,研究了TNF受体相关因子6 (TRAF6) 在CTLA-4无化和降解中的作用.
- 利用TRAF6缺乏的小鼠和逆转录病毒基因转移来评估T细胞TRAF6在CTLA-4调控中的内在功能.
- 采用OX40激动剂模型来探索OX40-TRAF6信号轴控制抗瘤免疫力.
主要成果:
- 确定了TRAF6作为Lys63相关的泛化和CTLA-4随后的溶酶体降解的关键媒介.
- 证明TRAF6以T细胞内在的方式促进CTLA-4降解,依赖于其RING域,从而增强CD8+T细胞抗瘤免疫力.
- 表明OX40-TRAF6轴驱动CTLA-4降解,在临床前模型和人类癌症中影响抗瘤反应.
结论:
- OX40-TRAF6信号通路是CTLA-4稳定性和T细胞介导的抗瘤免疫力的关键调节者.
- 针对OX40-TRAF6轴是克服ICB耐药性和提高癌症免疫疗法的有效性的一种有希望的策略.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928
01:27Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:22T Cell Activation and Clonal Selection
753
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
753